Speaker: Professor Dr. James L. Januzzi
 

Novartis are pleased to invite cardiologists, nurses and other specialists working within heart failure to a Nordic digital meeting.
The topic for this meeting is reverse cardiac remodelling and impact on cardiac structure and pumping function for HFrEF patients. 
Speaker Professor Dr. James L. Januzzi (Professor of Medicine at Harvard Medical School) will share learnings from PROVE-HF*
and give his view on HF treatment today.

 

Welcome!
Novartis, Cardiovascular, Renal & Metabolism


Registration

 

Please click here for registration. A confirmation will be received via email and one day before the meeting you will receive the link for the meeting.

 

Observera att för deltagande behöver du din huvudmans godkännande. Mötet är kostnadsfritt och Novartis står för föreläsararvode.
Genom att anmäla dig till mötet accepterar du att vi behandlar dina uppgifter i enlighet med vår integritetsskyddspolicy.


*PROVE-HF
Prospective Study of Biomarkers, Symptom Improvement and Ventricular Remodeling During Entresto Therapy for Heart Failure Januzzi JL. et al. Association of Change
in N-Terminal Pro–B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure
With Reduced Ejection Fraction, JAMA 2019;322(11):1085–1095.
Enligt avtalet om information och utbildning mellan Läkemedelsindustriföreningen och SKL har denna inbjudan till utbildning skickats till din huvudman.
Försändelsen är utsänd med stöd av uppgifter ur Hälso- och Sjukvårdens Adressregister, HSAR, av Novartis AB, som är anslutet till Integritetsskyddsprogrammet för HSAR.
Ytterligare information erhålls av IQVIA Solutions Sweden AB, e-mail: [email protected].
Program 
Welcome and introduction
Learnings from PROVE-HF by Professor Dr. James L.Januzzi
Questions, discussion and summary
Closing
Professor Dr. James L. Januzzi
James L. Januzzi, MD attended New York Medical College, graduating as the top-ranked student in 1994. He then performed a residency in internal medicine at Brigham and Women’s Hospital, followed by fellowship in cardiology and cardiac ultrasound at Massachusetts General Hospital, where he joined the full time staff in 2000. Presently, Dr. Januzzi is the Hutter Family Professor of Medicine at Harvard Medical School. Dr. Januzzi’s research has contributed to the understanding of cardiac biomarker testing and drug therapies for heart disease for the treatment of patients suffering from heart failure, diabetes and acute coronary syndromes. Dr. Januzzi has published more than 650 manuscripts, book chapters and review articles, has edited five text books. He is an Associate Editor at both JACC and JACC Heart Failure and is a Trustee at the American College of Cardiology and Fellow of the ESC and member of the ESC Heart Failure Association.
SE2103080226
×

Ask Speakers

×

Medical Information Request